bispecific antibody (follicular lymphoma)

Idelalisib(Zydelig)

C₂₂H₁₈FN₇O · Rx

anti-CD22 degrader-antibody conjugates (non-Hodgkin lymphoma/NSCLC)

anti-CD19 CAR T-cell therapy (B-cell non-Hodgkin lymphoma)

Non-Hodgkin's lymphoma vaccine (XEME Biopharma)

Non-Hodgkin's lymphoma vaccine(CellGenix GmbH)

anti-CD19 CAR T-cell therapy (non-Hodgkin lymphoma/acute lymphoblastic leukemia)

allogeneic CAR T-cell therapy

dual anti-CD19 CAR T-cell therapy/PD-1 checkpoint inhibitor (non-Hodgkin lymphoma/B-cell lymphoma)

follicular stem cells